会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 37. 发明授权
    • Triazine derivatives
    • 三嗪衍生物
    • US08444879B2
    • 2013-05-21
    • US12227042
    • 2007-05-02
    • Thomas EhlisElek Borsos
    • Thomas EhlisElek Borsos
    • C07D251/52C07D251/70C07D403/12C07D403/14A61Q17/04A61K8/49
    • C07D251/52C07D251/70
    • Disclosed are triazine derivatives of formula wherein X1 is a bivalent radical of formula A and A′ independently from each other are unsubstituted or substituted, straight-chain or branched C1-C12alkylene, which is optionally interrupted by C5-C12cycloalkylene, N, O or S; C5-C12cycloalkylene; biphenylene; C6-C10arylene; or C5-C10arylene-(C1-C12alkylene); R1 is a radical of formula R2 and R3 independently from each other are hydrogen; C1-C12alkyl; OR7; NR7R8; C6-C10aryl; X2 is O, or NH; W1 is C1-C20alkyl; or a group Sp-Sil; Sp is a straight-chain or branched saturated or single or multiple unsaturated C3-C12 hydrocarbon; Sil is a silane; an oligosiloxane; or a polysiloxane moiety; and R4, R5 R6, R7, R8 and R9 independently from each other are hydrogen; C1-C12alkyl; or C3-C12cycloalkyl.
    • 公开了下式的三嗪衍生物其中X1是式A的二价基团,A'彼此独立地是未取代或取代的直链或支链C 1 -C 12亚烷基,其任选地被C 5 -C 12亚环烷基,N,O或S ; C5-C12环亚烷基; 联苯; C6-C10亚芳基 或C 5 -C 10亚芳基 - (C 1 -C 12亚烷基); R1是式R2和R3的基团彼此独立地是氢; C 1 -C 12烷基; OR7; NR7R8; C6-C10芳基; X2是O或NH; W1是C1-C20烷基; 或一组Sp-Sil; Sp是直链或支链饱和或单或多不饱和C 3 -C 12烃; 硅是硅烷; 低聚硅氧烷 或聚硅氧烷部分; R 4,R 5,R 6,R 7,R 8和R 9彼此独立地为氢; C 1 -C 12烷基; 或C 3 -C 12环烷基。